Q: How would you summarize your study for a lay audience?
Given the rise in brain-based conditions and the growing development and investment in neurotechnologies to target them, it is important to understand how the public views these interventions and whether they would be willing to use them. To explore this, we conducted a survey of over 1,000 U.S. adults to examine perceptions of four neurotechnologies designed to treat severe mood, memory, or motor symptoms.
Q: What question were you investigating?
One of the goals of the recently created Neurotech Justice Accelerator at Mass General Brigham (NJAM), a Dana Center for Neuroscience & Society, is to better understand public views about emerging neurotechnologies. We investigated how the U.S. public perceives different neurotechnologies for…